XML 114 R28.htm IDEA: XBRL DOCUMENT v3.25.3
Restatement of Prior Period Financial Statements (Tables)
 9 Months Ended
Sep. 30, 2025
Restatement of Prior Period Financial Statements [Abstract]  
Schedule of Condensed Consolidated Statements of Operations The impact of these reclassifications and restatements on the Company’s condensed consolidated statements of operations for the three and nine months ended September 30, 2024, is shown below:
   For the three months ended September 30, 2024 
   As previously
reported		   Reclassification   Restatement   As adjusted 
Revenue  $81,636   $
-
    
-
   $81,636 
Cost of goods sold   145,201    
-
   (137,204)   7,997 
Gross profit  $(63,565)  $
-
   $137,204   $73,639 
Operating expenses:                    
General and administrative expenses   1,039,092    (532,305)   99    506,886 
Research and development expenses   157,741    
-
    28,937    186,678 
Sales and marketing   633,570    (103,154)   108,168    638,584 
Acquisition and integration   
-
    635,459    
-
    635,459 
Depreciation and amortization   
-
    
-
    
-
    
-
 
Total operating expenses   1,830,403    
-
    137,204    1,967,607 
Loss from operations  $(1,893,968)  $
-
   $
-
   $(1,893,968)

 

   For the nine months ended September 30, 2024 
   As previously
reported		   Reclassification   Restatement   As adjusted 
Revenue  $183,631   $
-
   $
-
   $183,631 
Cost of goods sold   155,210    
-
   (137,204)   18,006 
Gross profit  $28,421   $
-
   $137,204   $165,625 
Operating expenses:                    
General and administrative expenses   2,462,469    (1,398,008)   99    1,064,461 
Research and development expenses   431,054    
-
    28,937    459,991 
Sales and marketing   1,758,156    (103,154)   108,168    1,763,170 
Acquisition and integration   
-
    1,501,261    
-
    1,501,261 
Depreciation and amortization   
-
    
-
    
-
    
-
 
Total operating expenses   4,651,679    
-
    137,204    4,788,883 
Loss from operations  $(4,623,258)  $
-
   $
-
   $(4,623,258)